Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-C-2789 | ATB-346 CAS:1226895-20-0 | Otenaproxesul(ATB-346),an orally active non-steroidal anti-inflammatory drug(NSAID),inhibits cyclooxygenase-1 and 2(COX-1 and 2).Otenaproxesul possesses antiinflammatory and antinociceptive activities. | price> |
| R-R-4489 | BTX161 CAS No.2052301-24-1 | BTX161/CAS No.2052301-24-1, a Thalidomide analog, is a potent CKIα degrader. BTX161 mediates degradation of CKIα better than Lenalidomide in human AML cells and activates DNA damage response (DDR) and p53, while stabilizing the p53 antagonist MDM2. | price> |
| R-C-2790 | AZD3839 CAS:1227163-84-9 | AZD3839 free base is a potent and selective orally active,brain-permeable BACE1 inhibitor(Ki=26nM).AZD3839 free base shows 14 and>1000-fold selectivity against BACE2 and cathepsin D,respectively.AZD3839 free base exhibits dose-and time-dependent lowering of plasma,brain,and cerebrospinal fluid Aβ levels in mouse,guinea pig,and non-human primate. | price> |
| R-R-4490 | CK2/ERK8-IN-1 CAS No.1085822-09-8 | CK2/ERK8-IN-1/CAS No.1085822-09-8 is a dual casein kinase 2 (CK2) (Ki of 0.25 µM) and ERK8 (MAPK15, ERK7) inhibitor with IC50s of 0.50 μM. CK2/ERK8-IN-1 also binds to PIM1, HIPK2 (homeodomain-interacting protein kinase 2), and DYRK1A with Kis of 8.65 µM, 15.25 µM, and 11.9 µM, respectively. CK2/ERK8-IN-1 has pro-apoptotic efficacy. | price> |
| R-C-2791 | Iguratimod CAS:123663-49-0 | Iguratimod is an antirheumatic agent,acts as an inhibitor of COX-2,with an IC50 of 20μM(7.7μg/mL),but shows no effect on COX-1.Iguratimod also inhibits macrophage migration inhibitory factor(MIF)with an IC50 of 6.81μM. | price> |
| R-R-4491 | Epiblastin A CAS No.16470-02-3 | Epiblastin A/CAS No.16470-02-3 is an ATP competitive casein kinase 1 (CK1) inhibitor with IC50s of 8.9, 0.5, and 4.7 µM for CK1α, CK1δ, and CK1 ɛ, respectively. Epiblastin A induces reprogramming of epiblast stem cells into embryonic stem cells by inhibition of CK1. | price> |
| R-C-2792 | TCN 238 CAS:125404-04-8 | TCN238 is an orally bioavailable mGlu4 receptor positive allosteric modulator (PAM)with an EC50 of 1μM. | price> |
| R-C-3322 | DSPE-PEG550-RGD(ARG-GLY-ASP) | Phospholipid polyethylene glycol RGD can be used for passive targeting,active targeting and drug delivery of micelles and vesicles.DSPE is a saturated 18 carbon phospholipid,which is commonly used in the synthesis of liposomes. Polyethylene glycol (PEG)-coupled DSPE is hydrophilic and can be used for drug delivery,gene transfection and biomolecular modification.PEGylation of phospholipid significantly improved the blood circulation time and stability of capsule drugs.Polyethylene glycol can enhance solubility and stability,reduce the surface nonspecific binding of charged molecules,and reduce the immunogenicity of peptides. | price> |
| R-R-4492 | MRT00033659 CAS No.1401731-54-1 | MRT00033659/CAS No.1401731-54-1 is a potent broad-spectrum kinase inhibitor of CK1 (IC50=0.9 µM for CK1δ) and CHK1 (IC50=0.23 µM). MRT00033659, a pyrazolo-pyridine analogue, induces p53 pathway activation and E2F-1 destabilisation. | price> |
| R-C-2793 | RuBi-Nicotine CAS:1256362-30-7 | Ruthenium-bisbipyridine-caged nicotine,excitable by irradiation with visible light.Undergoes rapid photolysis to release nicotine(<20 ns);exhibits a high quantum yield.Induces action potential propagation in Retzius neurons of leech ganglia with no detectable toxicity at a concentration of 1mM. | price> |
| R-C-3323 | DSPE-PEG750-RGD(ARG-GLY-ASP) | Phospholipid polyethylene glycol RGD can be used for passive targeting,active targeting and drug delivery of micelles and vesicles.DSPE is a saturated 18 carbon phospholipid,which is commonly used in the synthesis of liposomes. Polyethylene glycol (PEG)-coupled DSPE is hydrophilic and can be used for drug delivery,gene transfection and biomolecular modification.PEGylation of phospholipid significantly improved the blood circulation time and stability of capsule drugs.Polyethylene glycol can enhance solubility and stability,reduce the surface nonspecific binding of charged molecules,and reduce the immunogenicity of peptides. | price> |
| R-R-4493 | TMX-4113 CAS No.2766385-92-4 | TMX-4113/CAS No.2766385-92-4 is a degrader of phosphodiesterase 6D (PDE6D) and casein kinase 1α (CK1α). TMX-4113 can be used for the research of cancer. | price> |
| R-C-2794 | VU 0360223 CAS:1274859-33-4 | Potent negative allosteric modulator of mGlu5(IC50=61nM).Displays no activity at mGlu1-4 and mGlu7-8. | price> |
| R-C-3324 | DSPE-PEG350-BTC | In order to improve the accumulation of anticancer drugs in tumor and enhance the possibility of intracellular delivery,the stealth liposomes modified with arginine glycine aspartic acid (RGD) mimics were used as targeting vectors. Integrin was synthesized and covalently coupled with active polyethylene glycol phospholipid(DSPE-PEG-BTC) to form rgdm coupling compound (DSPE-PEG-RGDM).The binding of melanoma cells to dspe-peg-rgdm was studied by pH sensitive probe bcecf-am. | price> |
| R-R-4494 | LH846 CAS No.639052-78-1 | LH846/CAS No.639052-78-1 is a selective inhibitor of CKIδ, with an IC50 of 290 nM, and less potently inhibits CKIα and CKIε, with IC50s of 2.5 μM and 1.3 μM, respectively. | price> |
| R-C-2795 | Alcaftadine (R89674) CAS:147084-10-4 | Alcaftadine(R89674)is a histamine H1 receptor antagonist,which is used to prevent eye irritation brought on by allergic conjunctivitis.Alcaftadine is a broad-spectrum antihistamine displaying a high affinity for histamine H1 and H2 receptors and a lower affinity for H4 receptors.Alcaftadine also exhibits modulatory action on immune cell recruitment and mast cell stabilizing effects. | price> |
| R-C-3325 | DSPE-PEG550-BTC | In order to improve the accumulation of anticancer drugs in tumor and enhance the possibility of intracellular delivery,the stealth liposomes modified with arginine glycine aspartic acid (RGD) mimics were used as targeting vectors. Integrin was synthesized and covalently coupled with active polyethylene glycol phospholipid(DSPE-PEG-BTC) to form rgdm coupling compound (DSPE-PEG-RGDM).The binding of melanoma cells to dspe-peg-rgdm was studied by pH sensitive probe bcecf-am. | price> |
| R-R-4495 | Casein Kinase II Inhibitor IV CAS No.863598-09-8 | Casein Kinase II Inhibitor IV/CAS No.863598-09-8 is a potent, ATP-competitive of casein kinase II inhibitor with an IC50 of 9 nM. Casein Kinase II Inhibitor IV ia also a human keratinocytes (NHEK) differentiation inducer. | price> |
| R-C-2796 | Maropitant CAS:147116-67-4 | Maropitant is a neurokinin(NK1)receptor antagonist.IC50 value:Target:NK1 receptor Maropitant is the first NK1 receptor antagonist developed to treat and prevent emesis in dogs. | price> |
| R-C-3326 | DSPE-PEG750-BTC | In order to improve the accumulation of anticancer drugs in tumor and enhance the possibility of intracellular delivery,the stealth liposomes modified with arginine glycine aspartic acid (RGD) mimics were used as targeting vectors. Integrin was synthesized and covalently coupled with active polyethylene glycol phospholipid(DSPE-PEG-BTC) to form rgdm coupling compound (DSPE-PEG-RGDM).The binding of melanoma cells to dspe-peg-rgdm was studied by pH sensitive probe bcecf-am. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


